Third party auditing and certification of excipient suppliers can assist in the development, manufacture and supply of safe and effective medicinal products.
On July 15, 2015, FDA held a public meeting to seek input on the reauthorization of the Prescription Drug User Fee Act (2002) (PDUFA). David R. Schoneker presented comments during the meeting.
IPEC-Americas Publishes Position Paper on Accelerated Stability
IPEC-Americas submits comments on the reauthorization of the Generic Drug User Fee Amendments of 2012.
In just one more year, during 2016, IPEC-Americas will mark and celebrate its 25th Anniversary! This month's Insider e-newsletter highlights the very beginning: the birth of IPEC-Americas.
The International Pharmaceutical Excipient Council Federation, (IPEC Federation) announces the availability of the IPEC Technically Unavoidable Particle Profile Guide.